These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25374442)

  • 1. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.
    D'Abramo A; Zingaropoli MA; Oliva A; D'Agostino C; Al Moghazi S; De Luca G; Iannetta M; Mastroianni CM; Vullo V
    Mediators Inflamm; 2014; 2014():192594. PubMed ID: 25374442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.
    D'Abramo A; Zingaropoli MA; Oliva A; D'Agostino C; Al Moghazi S; De Luca G; Iannetta M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V
    PLoS One; 2016; 11(2):e0149601. PubMed ID: 26913505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.
    Merlini E; Luzi K; Suardi E; Barassi A; Cerrone M; Martínez JS; Bai F; D'Eril GV; Monforte AD; Marchetti G
    PLoS One; 2012; 7(9):e46073. PubMed ID: 23029393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors.
    Bernal E; Martinez M; Torres A; Guillamón CF; Alcaraz A; Alcaraz MJ; Muñoz A; Valero S; Botella C; Campillo JA; Cano A; Minguela A
    Antiviral Res; 2019 Feb; 162():163-170. PubMed ID: 30593833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening.
    Alcaraz MJ; Alcaraz A; Teruel-Montoya R; Campillo JA; de la Torre A; Muñoz Á; Tomás C; Puche G; Báguena C; Cano A; Minguela A; Bernal E
    Aging (Albany NY); 2021 Jul; 13(14):18094-18105. PubMed ID: 34310343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the CaroVIH Study.
    Sainz T; Álvarez-Fuente M; Navarro ML; Díaz L; Rojo P; Blázquez D; de José MI; Ramos JT; Serrano-Villar S; Martínez J; Medrano C; Muñoz-Fernández MÁ; Mellado MJ;
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):42-9. PubMed ID: 23982657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
    Park YJ; Shin YJ; Kim WU; Cho CS
    Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
    Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
    AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment.
    Bernal Morell E; Serrano Cabeza J; Muñoz Á; Marín I; Masiá M; Gutiérrez F; Cano A
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):648-53. PubMed ID: 27005326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
    Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
    Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen.
    Squillace N; Trabattoni D; Muscatello A; Sabbatini F; Maloberti A; Giannattasio C; Masetti M; Fenizia C; Soria A; Clerici M; Gori A; Bandera A
    J Antimicrob Chemother; 2018 Aug; 73(8):2162-2170. PubMed ID: 29897513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.
    Kelesidis T; Kendall MA; Yang OO; Hodis H; Currier JS
    AIDS Res Hum Retroviruses; 2013 Jun; 29(6):938-48. PubMed ID: 23351153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection.
    McLaughlin MM; Ma Y; Scherzer R; Rahalkar S; Martin JN; Mills C; Milush J; Deeks SG; Hsue PY
    JAMA Netw Open; 2020 Oct; 3(10):e2018099. PubMed ID: 33119103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection.
    Saeidi A; Chong YK; Yong YK; Tan HY; Barathan M; Rajarajeswaran J; Sabet NS; Sekaran SD; Ponnampalavanar S; Che KF; Velu V; Kamarulzaman A; Larsson M; Shankar EM
    Cell Immunol; 2015 Sep; 297(1):19-32. PubMed ID: 26071876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell activation predicts carotid artery stiffness among HIV-infected women.
    Kaplan RC; Sinclair E; Landay AL; Lurain N; Sharrett AR; Gange SJ; Xue X; Parrinello CM; Hunt P; Deeks SG; Hodis HN
    Atherosclerosis; 2011 Jul; 217(1):207-13. PubMed ID: 21492857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
    Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
    HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease.
    Nascimento MM; Hayashi SY; Riella MC; Lindholm B
    Braz J Med Biol Res; 2014 Nov; 47(11):995-1002. PubMed ID: 25296363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
    Serrano-Villar S; Sainz T; Lee SA; Hunt PW; Sinclair E; Shacklett BL; Ferre AL; Hayes TL; Somsouk M; Hsue PY; Van Natta ML; Meinert CL; Lederman MM; Hatano H; Jain V; Huang Y; Hecht FM; Martin JN; McCune JM; Moreno S; Deeks SG
    PLoS Pathog; 2014 May; 10(5):e1004078. PubMed ID: 24831517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.
    Ross AC; Rizk N; O'Riordan MA; Dogra V; El-Bejjani D; Storer N; Harrill D; Tungsiripat M; Adell J; McComsey GA
    Clin Infect Dis; 2009 Oct; 49(7):1119-27. PubMed ID: 19712036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.